Q1 2026 Geron Corp Earnings Call Transcript
Hello, and welcome to Geron Corporation first quarter 2026 earnings call. (Operator Instructions) Please advised that today's conference will be recorded.
I'll now turn the call over to Dawn Schottlandt, Senior Vice President, Investor Relations and Corporate Affairs. You may begin.
Good morning, everyone. Welcome to the Geron Corporation first quarter 2026 earnings conference call. Before we begin, please note that during the course of this presentation and question-and-answer session, we will be making forward-looking statements regarding future events, performance plans, expectations, and other projections, including those relating to our 2026 financial guidance, our current RYTELO commercialization strategy, and related opportunities in the US and the EU, the therapeutic potential of RYTELO, other anticipated clinical and commercial events and related timelines, the sufficiency of our financial resources, and other statements that are not historical
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
